Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Abiprubart by Kiniksa Pharmaceuticals for Sicca Syndrome (Sjogren): Likelihood of Approval
Abiprubart is under clinical development by Kiniksa Pharmaceuticals and currently in Phase II for Sicca Syndrome (Sjogren). According to GlobalData,...
Data Insights
Abiprubart by Kiniksa Pharmaceuticals for Rheumatoid Arthritis: Likelihood of Approval
Abiprubart is under clinical development by Kiniksa Pharmaceuticals and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase...